Calcivis closes $4.1m round with Scottish support

Scottish Investment Bank was among the returning investors.

Calcivis, a medical devices developer focusing on the dentistry market, has raised £3.15m ($4.1m) in its latest equity funding round.

The money was raised from existing investors Archangel Investors, Julz, and the state-backed Scottish Investment Bank. The funding will be used to support the completion of the US Food and Drug Administration’s pre-market approval process for the Calcivis Imaging System.

Kerry Sharp, head of Scottish Investment Bank, said: "We're pleased to be co-investing with Archangels and Julz Co to help Calcivis gain FDA approval and launch the product in the US. We've assisted the company on its growth journey and it's now showing promising commercial development with the launch of its imaging system in the UK earlier this year a significant event for preventive dentistry.”

See more from this Government Report: Scotland


Supporting articles

Copyright Mawsonia Limited 2010. Please don't cut articles from or the PDF and redistribute by email or post to the web without written permission.